While grenades have been mentioned in situations related to the military, they have never been mentioned in scientific research dealing with cancer. That is, until now. A new innovative drug by researchers at the Johns Hopkins Kimmel Cancer Center, in collaboration with Danish scientists, works like a “molecular grenade”; it can move through the bloodstream until activation by specific cancer proteins.
The drug is made from a weed-like plant that has demonstrated its ability to destroy cancer and direct blood sources, working and safeguarding healthy blood tissues and vessels. The drug, G202, is made from Thapsia gargancia, a weed that grows in the Mediterranean area. The plant produces thapsigargin, a product that has been known to be toxic to animals.
The investigators stated that, through laboratory studies, they tested a three-day course of drug G202. Within 30 days, the drug can decrease the size of human prostate tumors found in mice to about 50%. When compared to chemotherapy drug docetaxel, G202 outperformed it and reduced seven of nine human prostate tumors in a 21-day period.
Apart from the study done with tumors, G202 was able to produce regression in illness like bladder cancer, breast cancer, and kidney cancer. The findings are presented in a recent issue of the journal Science Translational Medicine.
Source: redOrbit (http://s.tt/1hyjX)
Posts
No comments:
Post a Comment
You only need to enter your comment once! Comments will appear once they have been moderated. This is so as to stop the would-be comedian who has been spamming the comments here with inane and often offensive remarks. You know who you are!